Clinical trial
A Study of Safety and Effectiveness of Golimumab in Participants With Active…
NCT00361335 · Centocor, Inc., Industry · Completed
Key facts
| NCT number | NCT00361335 |
|---|---|
| Title | A Study of Safety and Effectiveness of Golimumab in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy |
| Official title | A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFa Monoclonal Antibody, Administered Intravenously, in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy |
| Lead sponsor | Centocor, Inc., Industry |
| Collaborators | Schering-Plough Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Golimumab, Methotrexate, Placebo |
| Enrollment | 643 |
| Start date | Sep 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Sep 1, 2009 |
| First posted | Aug 8, 2006 |
| Last update posted | Jul 29, 2014 |
| Countries | Argentina, Australia, Colombia, Germany, Hungary, Latvia, Lithuania, Malaysia, Malta, Mexico, New Zealand, Peru and 3 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: